Will Codexis Incorporated (NASDAQ:CDXS) Run Out of Steam Soon? Short Interest is Up

January 15, 2018 - By Stephen Andrade

 Will Codexis Incorporated (NASDAQ:CDXS) Run Out of Steam Soon? Short Interest is Up

Investors sentiment increased to 2.2 in 2017 Q3. Its up 0.20, from 2 in 2017Q2. It increased, as 2 investors sold Codexis, Inc. shares while 13 reduced holdings. 9 funds opened positions while 24 raised stakes. 25.60 million shares or 11.04% more from 23.06 million shares in 2017Q2 were reported.
Parametric Assocs Ltd Liability Corporation invested in 0% or 11,719 shares. Opaleye Mngmt holds 4% in Codexis, Inc. (NASDAQ:CDXS) or 1.70 million shares. Envestnet Asset Mgmt has invested 0% in Codexis, Inc. (NASDAQ:CDXS). Financial Bank Of New York Mellon stated it has 0% of its portfolio in Codexis, Inc. (NASDAQ:CDXS). Goldman Sachs Group Inc has 0% invested in Codexis, Inc. (NASDAQ:CDXS). Metropolitan Life Insur invested in 28,437 shares. 18,236 were reported by Voya Inv Mgmt Limited Liability Com. California-based Schwab Charles Invest has invested 0% in Codexis, Inc. (NASDAQ:CDXS). Vanguard Grp Inc has invested 0% in Codexis, Inc. (NASDAQ:CDXS). Renaissance Techs Ltd Liability has invested 0.01% in Codexis, Inc. (NASDAQ:CDXS). Nationwide Fund Advsr holds 0% or 24,282 shares in its portfolio. Strs Ohio accumulated 111,900 shares or 0% of the stock. Geode Cap Mngmt Ltd Liability Company, Massachusetts-based fund reported 304,951 shares. Jpmorgan Chase And holds 60 shares. Howe And Rusling Incorporated invested in 5,000 shares.

Since September 14, 2017, it had 0 insider purchases, and 1 insider sale for $6.12 million activity.

The stock of Codexis Incorporated (NASDAQ:CDXS) registered an increase of 2.84% in short interest. CDXS’s total short interest was 2.08M shares in January as published by FINRA. Its up 2.84% from 2.02M shares, reported previously. With 187,000 shares average volume, it will take short sellers 11 days to cover their CDXS’s short positions. The short interest to Codexis Incorporated’s float is 7.78%.

The stock decreased 0.55% or $0.05 during the last trading session, reaching $9. About 256,784 shares traded or 0.34% up from the average. Codexis, Inc. (NASDAQ:CDXS) has risen 27.19% since January 15, 2017 and is uptrending. It has outperformed by 10.49% the S&P500.

Codexis, Inc. discovers, develops, and sells protein catalysts. The company has market cap of $435.12 million. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable clients to perform chemistry screening. It currently has negative earnings. The firm also provides protein catalyst screening and protein engineering services.

Codexis, Inc. (NASDAQ:CDXS) Ratings Coverage

Among 4 analysts covering Codexis (NASDAQ:CDXS), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Codexis has $11 highest and $3.75 lowest target. $7.06’s average target is -21.56% below currents $9 stock price. Codexis had 8 analyst reports since August 12, 2015 according to SRatingsIntel. Zacks upgraded Codexis, Inc. (NASDAQ:CDXS) rating on Wednesday, August 26. Zacks has “Hold” rating and $3.75 target. The company was downgraded on Wednesday, August 12 by Zacks. H.C. Wainwright initiated Codexis, Inc. (NASDAQ:CDXS) rating on Wednesday, January 6. H.C. Wainwright has “Buy” rating and $6 target. Jefferies maintained the stock with “Buy” rating in Friday, October 13 report. The stock of Codexis, Inc. (NASDAQ:CDXS) earned “Equal-Weight” rating by First Analysis on Thursday, January 26. Ladenburg Thalmann upgraded the shares of CDXS in report on Wednesday, January 4 to “Buy” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.